AMP’s work in Europe is focused on fighting infectious diseases and improving public health infrastructure in newly independent states—which continue to be afflicted by poor health conditions associated with political, social, and economic uncertainties.
In the late 1990s, we conducted studies on the incidence of Haemophilus influenzae type b meningitis among children less than five years of age in Slovakia and Romania. We also carried out a study of pertussis among adults with chronic cough in France. The disease burden data derived from these studies are critical to inform decisions concerning routine vaccination schedules and consequently to reduce disease morbidity and mortality.
In the 2010s, AMP in collaboration with WHO Regional Offices, has developped ProVac IWG Initiative to support economical analysis integration in the process of news vaccines introduction (i.e rotavirus, pneumococcal diseases, Haemophilus influenzae de type b). This support has been provided to teams in 4 countries of WHO EURO region (Albania, Azerbaidjan, Croatia and Georgia).
Since 2008 Iniative SIVAC has also supported the creation of National Immunization Technical Advisory Groups (NITAGs) in 4 countries of WHO EURO region such as: Kazakhstan, Kirghizistan, Armenia and Moldavia.